{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T22:40:02Z","timestamp":1749508802382,"version":"3.41.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00417-025-06766-0","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T21:33:51Z","timestamp":1739309631000},"page":"1269-1278","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oscillatory photodynamic therapy in central serous chorioretinopathy"],"prefix":"10.1007","volume":"263","author":[{"given":"Nicola","family":"Valsecchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasiq","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1772-3558","authenticated-orcid":false,"given":"Jay","family":"Chhablani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"issue":"1","key":"6766_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40942-023-00443-2","volume":"9","author":"A Zarnegar","year":"2023","unstructured":"Zarnegar A, Ong J, Matsyaraja T, Arora S, Chhablani J (2023) Pathomechanisms in central serous chorioretinopathy: A recent update. Int J Retina Vitreous 9(1):3. https:\/\/doi.org\/10.1186\/s40942-023-00443-2","journal-title":"Int J Retina Vitreous"},{"key":"6766_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","volume":"48","author":"A Daruich","year":"2015","unstructured":"Daruich A, Matet A, Dirani A et al (2015) Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis. Prog Retin Eye Res 48:82\u2013118. https:\/\/doi.org\/10.1016\/j.preteyeres.2015.05.003","journal-title":"Prog Retin Eye Res"},{"key":"6766_CR3","doi-asserted-by":"publisher","first-page":"100973","DOI":"10.1016\/j.preteyeres.2021.100973","volume":"86","author":"RF Spaide","year":"2022","unstructured":"Spaide RF, Gemmy Cheung CM, Matsumoto H et al (2022) Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders. Prog Retin Eye Res 86:100973. https:\/\/doi.org\/10.1016\/j.preteyeres.2021.100973","journal-title":"Prog Retin Eye Res"},{"issue":"10","key":"6766_CR4","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1097\/IAE.0000000000001443","volume":"37","author":"A Daruich","year":"2017","unstructured":"Daruich A, Matet A, Marchionno L et al (2017) Acute Central SEROUS Chorioretinopathy: Factors influencing episode duration. Retina 37(10):1905\u20131915. https:\/\/doi.org\/10.1097\/IAE.0000000000001443","journal-title":"Retina"},{"issue":"12","key":"6766_CR5","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.4103\/ijo.IJO_1077_18","volume":"66","author":"D Hanumunthadu","year":"2018","unstructured":"Hanumunthadu D, Tan ACS, Singh SR, Sahu NK, Chhablani J (2018) Management of chronic central serous chorioretinopathy. Indian J Ophthalmol 66(12):1704\u20131714. https:\/\/doi.org\/10.4103\/ijo.IJO_1077_18","journal-title":"Indian J Ophthalmol"},{"issue":"12","key":"6766_CR6","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1136\/bjo.87.12.1453","volume":"87","author":"WM Chan","year":"2003","unstructured":"Chan WM, Lam DSC, Lai TYY, Tam BSM, Liu DTL, Chan CKM (2003) Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 87(12):1453\u20131458","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"6766_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/eye.2017.290","volume":"32","author":"A Rabiolo","year":"2018","unstructured":"Rabiolo A, Zucchiatti I, Marchese A et al (2018) Multimodal retinal imaging in central serous chorioretinopathy treated with oral eplerenone or photodynamic therapy. Eye 32(1):55\u201366. https:\/\/doi.org\/10.1038\/eye.2017.290","journal-title":"Eye"},{"issue":"10","key":"6766_CR8","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.ophtha.2018.04.021","volume":"125","author":"EHC van Dijk","year":"2018","unstructured":"van Dijk EHC, Fauser S, Breukink MB et al (2018) Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: The place trial. Ophthalmology 125(10):1547\u20131555. https:\/\/doi.org\/10.1016\/j.ophtha.2018.04.021","journal-title":"Ophthalmology"},{"issue":"6","key":"6766_CR9","first-page":"835","volume":"120","author":"U Schmidt-Erfurth","year":"2002","unstructured":"Schmidt-Erfurth U, Laqua H, Schl\u00f6tzer-Schrehard U, Viestenz A, Naumann GOH (2002) Histopathological changes following photodynamic therapy in human eyes. Arch Ophthalmol 120(6):835\u2013844","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"6766_CR10","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/IAE.0000000000003404","volume":"42","author":"JI Fern\u00e1ndez-Vigo","year":"2022","unstructured":"Fern\u00e1ndez-Vigo JI, Moreno-Morillo FJ, Valverde-Meg\u00edas A, Burgos-Blasco B, L\u00f3pez-Guajardo L, Donate-L\u00f3pez J (2022) Acute exudative maculopathy and bacillary layer detachment in patients with central serous chorioretinopathy after photodynamic therapy. Retina 42(5):859. https:\/\/doi.org\/10.1097\/IAE.0000000000003404","journal-title":"Retina"},{"issue":"10","key":"6766_CR11","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1001\/archopht.123.10.1347","volume":"123","author":"UEK Schnurrbusch","year":"2005","unstructured":"Schnurrbusch UEK, Jochmann C, Einbock W, Wolf S (2005) Complications after photodynamic therapy. Arch Ophthalmol 123(10):1347\u20131350. https:\/\/doi.org\/10.1001\/archopht.123.10.1347","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"6766_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s10384-008-0613-z","volume":"53","author":"PY Lee","year":"2009","unstructured":"Lee PY, Kim KS, Lee WK (2009) Severe choroidal ischemia following photodynamic therapy for pigment epithelial detachment and chronic central serous chorioretinopathy. Jpn J Ophthalmol 53(1):52\u201356. https:\/\/doi.org\/10.1007\/s10384-008-0613-z","journal-title":"Jpn J Ophthalmol"},{"issue":"16","key":"6766_CR13","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1038\/s41433-023-02509-9","volume":"37","author":"SR Singh","year":"2023","unstructured":"Singh SR, Got\u00e9 JT, Chhablani J (2023) Randomized controlled trials in central serous chorioretinopathy: A review. Eye 37(16):3306\u20133312. https:\/\/doi.org\/10.1038\/s41433-023-02509-9","journal-title":"Eye"},{"issue":"6","key":"6766_CR14","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3341\/kjo.2019.0065","volume":"33","author":"SR Noh","year":"2019","unstructured":"Noh SR, Kang MS, Kim K, Kim ES, Yu SY (2019) Comparison of focal and conventional verteporfin photodynamic therapy for chronic central serous chorioretinopathy. Korean J Ophthalmol 33(6):506\u2013513. https:\/\/doi.org\/10.3341\/kjo.2019.0065","journal-title":"Korean J Ophthalmol"},{"issue":"5","key":"6766_CR15","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/bjophthalmol-2016-309247","volume":"101","author":"PH Mehta","year":"2017","unstructured":"Mehta PH, Meyerle C, Sivaprasad S, Boon C, Chhablani J (2017) Preferred practice pattern in central serous chorioretinopathy. Br J Ophthalmol 101(5):587\u2013590. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-309247","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"6766_CR16","first-page":"166","volume":"6","author":"GA Peyman","year":"2011","unstructured":"Peyman GA, Tsipursky M, Nassiri N, Conway M (2011) Oscillatory photodynamic therapy for choroidal neovascularization and central serous retinopathy; a pilot study. J Ophthalmic Vis Res 6(3):166\u2013176","journal-title":"J Ophthalmic Vis Res"},{"issue":"3","key":"6766_CR17","doi-asserted-by":"publisher","first-page":"NP150","DOI":"10.1177\/11206721221149070","volume":"33","author":"E Boulanger","year":"2023","unstructured":"Boulanger E, Eller A, Chhablani J (2023) Distorted pupil and plant induced dermatitis. Eur J Ophthalmol 33(3):NP150\u2013NP151. https:\/\/doi.org\/10.1177\/11206721221149070","journal-title":"Eur J Ophthalmol"},{"key":"6766_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ajo.2016.07.026","volume":"170","author":"FHP Lai","year":"2016","unstructured":"Lai FHP, Ng DS, Bakthavatsalam M et al (2016) A multicenter study on the long-term outcomes of half-dose photodynamic therapy in chronic central serous chorioretinopathy. Am J Ophthalmol 170:91\u201399. https:\/\/doi.org\/10.1016\/j.ajo.2016.07.026","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"6766_CR19","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/IAE.0000000000001138","volume":"37","author":"CK Cheng","year":"2017","unstructured":"Cheng CK, Chang CK, Peng CH (2017) Comparison of photodynamic therapy using half-dose of verteporfin or half-fluence of laser light for the treatment of chronic central serous chorioretinopathy. Retina 37(2):325\u2013333. https:\/\/doi.org\/10.1097\/IAE.0000000000001138","journal-title":"Retina"},{"issue":"3","key":"6766_CR20","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00417-022-05836-x","volume":"261","author":"HMA Feenstra","year":"2023","unstructured":"Feenstra HMA, van Dijk EHC, van Rijssen TJ et al (2023) Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3. Graefes Arch Clin Exp Ophthalmol. 261(3):659\u2013668. https:\/\/doi.org\/10.1007\/s00417-022-05836-x","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"issue":"7","key":"6766_CR21","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/aos.14775","volume":"99","author":"TJ van Rijssen","year":"2021","unstructured":"van Rijssen TJ, van Dijk EHC, Scholz P et al (2021) Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser. Acta Ophthalmol 99(7):805\u2013811. https:\/\/doi.org\/10.1111\/aos.14775","journal-title":"Acta Ophthalmol"},{"key":"6766_CR22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12886-020-01796-0","volume":"21","author":"J Pichai","year":"2021","unstructured":"Pichai J, Vanchalerm B, Mansing R (2021) One-year results of half-dose versus one-third-dose photodynamic therapy in chronic or recurrent central serous chorioretinopathy. BMC Ophthalmol 21:30. https:\/\/doi.org\/10.1186\/s12886-020-01796-0","journal-title":"BMC Ophthalmol"},{"issue":"5","key":"6766_CR23","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.ajo.2014.01.022","volume":"157","author":"M Nicol\u00f3","year":"2014","unstructured":"Nicol\u00f3 M, Eandi CM, Alovisi C et al (2014) Half-fluence versus half-dose photodynamic therapy in chronic central serous chorioretinopathy. Am J Ophthalmol 157(5):1033-1037.e2. https:\/\/doi.org\/10.1016\/j.ajo.2014.01.022","journal-title":"Am J Ophthalmol"},{"key":"6766_CR24","doi-asserted-by":"publisher","first-page":"102081","DOI":"10.1016\/j.pdpdt.2020.102081","volume":"33","author":"MG Altinel","year":"2021","unstructured":"Altinel MG, Kanra AY, Totuk OMG, Ardagil A, Kabadayi K (2021) Comparison of half-dose versus half-fluence versus standard photodynamic therapy in chronic central serous chorioretinopathy. Photodiagn Photodyn Ther 33:102081. https:\/\/doi.org\/10.1016\/j.pdpdt.2020.102081","journal-title":"Photodiagn Photodyn Ther"},{"key":"6766_CR25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ajo.2020.04.022","volume":"217","author":"C Iovino","year":"2020","unstructured":"Iovino C, Au A, Chhablani J et al (2020) Choroidal anatomic alterations after photodynamic therapy for chronic central serous chorioretinopathy: A multicenter study. Am J Ophthalmol 217:104\u2013113. https:\/\/doi.org\/10.1016\/j.ajo.2020.04.022","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"6766_CR26","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s00417-017-3626-9","volume":"255","author":"A Russo","year":"2017","unstructured":"Russo A, Turano R, Morescalchi F et al (2017) Comparison of half-dose photodynamic therapy and 689 nm laser treatment in eyes with chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 255(6):1141\u20131148. https:\/\/doi.org\/10.1007\/s00417-017-3626-9","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"6766_CR27","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/IAE.0000000000003686","volume":"43","author":"HMA Feenstra","year":"2023","unstructured":"Feenstra HMA, Diederen RMH, Lamme MJCM et al (2023) Increasing evidence for the safety of fovea-involving half-dose photodynamic therapy for chronic central serous chorioretinopathy. Retina 43(3):379\u2013388. https:\/\/doi.org\/10.1097\/IAE.0000000000003686","journal-title":"Retina"},{"issue":"9","key":"6766_CR28","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1097\/IAE.0000000000001005","volume":"36","author":"JK Luttrull","year":"2016","unstructured":"Luttrull JK (2016) Low-intensity\/high-density subthreshold diode micropulse laser for central serous chorioretinopathy. Retina 36(9):1658\u20131663. https:\/\/doi.org\/10.1097\/IAE.0000000000001005","journal-title":"Retina"},{"issue":"2","key":"6766_CR29","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s40123-020-00250-0","volume":"9","author":"EHC van Dijk","year":"2020","unstructured":"van Dijk EHC, van Rijssen TJ, Subhi Y, Boon CJF (2020) Photodynamic therapy for chorioretinal diseases: A practical approach. Ophthalmol Ther 9(2):329\u2013342. https:\/\/doi.org\/10.1007\/s40123-020-00250-0","journal-title":"Ophthalmol Ther"},{"issue":"4","key":"6766_CR30","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.ajo.2006.04.028","volume":"142","author":"V Isola","year":"2006","unstructured":"Isola V, Pece A, Parodi MB (2006) Choroidal ischemia after photodynamic therapy with verteporfin for choroidal neovascularization. Am J Ophthalmol 142(4):680\u2013683. https:\/\/doi.org\/10.1016\/j.ajo.2006.04.028","journal-title":"Am J Ophthalmol"},{"key":"6766_CR31","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.2147\/OPTH.S359302","volume":"16","author":"AJ Sumnicht","year":"2022","unstructured":"Sumnicht AJ, Chalam KV, Sierpina DI (2022) Photodynamic therapy-induced acute exudative maculopathy (PAEM): Prevalence impact and management strategies. Clin Ophthalmol 16:3145\u20133154. https:\/\/doi.org\/10.2147\/OPTH.S359302","journal-title":"Clin Ophthalmol"},{"issue":"12","key":"6766_CR32","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1038\/sj.eye.6702278","volume":"20","author":"MP Shyong","year":"2006","unstructured":"Shyong MP, Chen SJ, Lee FL, Tsao YP, Hsu WM (2006) Increased and persisted subretinal haemorrhage after photodynamic therapy for choroidal neovascularization secondary to angioid streaks. Eye 20(12):1420\u20131422. https:\/\/doi.org\/10.1038\/sj.eye.6702278","journal-title":"Eye"},{"issue":"13","key":"6766_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1167\/iovs.65.13.39","volume":"65","author":"E Sadeghi","year":"2024","unstructured":"Sadeghi E, Valsecchi N, Ibrahim MN et al (2024) Three-dimensional choroidal vessels assessment in age-related macular degeneration. Invest Ophthalmol Vis Sci 65(13):39. https:\/\/doi.org\/10.1167\/iovs.65.13.39","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6766_CR34","doi-asserted-by":"publisher","first-page":"102704","DOI":"10.1016\/j.pdpdt.2021.102704","volume":"37","author":"S Penas","year":"2022","unstructured":"Penas S, Beato J, Rosinha P et al (2022) Longitudinal multimodal functional macular analysis after half-dose photodynamic therapy for central serous chorioretinopathy. Photodiagn Photodyn Ther 37:102704. https:\/\/doi.org\/10.1016\/j.pdpdt.2021.102704","journal-title":"Photodiagn Photodyn Ther"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06766-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-025-06766-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06766-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T22:04:19Z","timestamp":1749506659000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-025-06766-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["6766"],"URL":"https:\/\/doi.org\/10.1007\/s00417-025-06766-0","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"type":"print","value":"0721-832X"},{"type":"electronic","value":"1435-702X"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"28 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the University of Pittsburgh and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}